These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3823092)

  • 21. A.E. Bennett award paper. Experimental approaches to human stress research: assessment of neurobiological mechanisms of stress in volunteers and psychiatric patients.
    Breier A
    Biol Psychiatry; 1989 Sep; 26(5):438-62. PubMed ID: 2551397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation.
    Davidson M; Kahn RS; Powchik P; Warne P; Losonczy MF; Kaminsky R; Apter S; Jaff S; Davis KL
    Arch Gen Psychiatry; 1991 Jan; 48(1):73-6. PubMed ID: 1670618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of debrisoquin and haloperidol on plasma homovanillic acid concentration in schizophrenic patients.
    Davidson M; Losonczy MF; Mohs RC; Lesser JC; Powchik P; Freed LB; Davis BM; Mykytyn VV; Davis KL
    Neuropsychopharmacology; 1987 Dec; 1(1):17-23. PubMed ID: 3509064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations.
    Davidson M; Kahn RS; Knott P; Kaminsky R; Cooper M; DuMont K; Apter S; Davis KL
    Arch Gen Psychiatry; 1991 Oct; 48(10):910-3. PubMed ID: 1929760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of haloperidol decanoate on plasma homovanillic acid in chronic schizophrenic patients.
    Chang WH; Lin SK; Juang DJ; Chen LC; Yang CH; Lane HY; Jann MW
    Biol Psychiatry; 1993 Apr; 33(7):557-9. PubMed ID: 8513043
    [No Abstract]   [Full Text] [Related]  

  • 26. Plasma homovanillic acid levels and subtyping of schizophrenia.
    Chang WH; Chen TY; Lee CF; Hung JC; Hu WH; Yeh EK
    Psychiatry Res; 1988 Mar; 23(3):239-44. PubMed ID: 3387499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurements of plasma homovanillic acid in schizophrenic patients.
    Davidson M; Kahn RS; Stern RG; Harvey PD; Keefe R; Knott P; Apter S; Webster L; Davis KL
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():521A-522A. PubMed ID: 1354058
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of debrisoquin on plasma homovanillic acid concentration in schizophrenic patients.
    Davidson M; Losonczy MF; Mohs RC; Powchick P; Freed LB; Kaminsky R; Davis KL
    Psychopharmacol Bull; 1987; 23(3):407-10. PubMed ID: 3432512
    [No Abstract]   [Full Text] [Related]  

  • 29. Dopamine and schizophrenia.
    Crow TJ; Johnstone EC; Deakin JF; Longden A
    Lancet; 1976 Sep; 2(7985):563-6. PubMed ID: 60635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroleptic treatment, symptoms of schizophrenia, and plasma homovanillic acid concentrations revisited.
    Volavka J; Douyon R; Convit A; Czobor P; Cooper TB
    Arch Gen Psychiatry; 1992 Dec; 49(12):999-1000. PubMed ID: 1449388
    [No Abstract]   [Full Text] [Related]  

  • 31. Inter- and intra-individual variability in the levels of plasma homovanillic acid in schizophrenic patients.
    Zumárraga M; Dávila R; González-Torres MA; Anguiano JB; Zabalo MJ; Basterreche N; Arrúe A; Zamalloa MI; Guimón J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):713-9. PubMed ID: 17291661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients. Preliminary results.
    Wolkowitz OM; Breier A; Doran A; Kelsoe J; Lucas P; Paul SM; Pickar D
    Arch Gen Psychiatry; 1988 Jul; 45(7):664-71. PubMed ID: 3289524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma homovanillic acid and prognosis in schizophrenia.
    Baker NJ; Kirch DG; Waldo M; Bell J; Adler LE; Hattox S; Murphy R; Freedman R
    Biol Psychiatry; 1991 Jan; 29(2):192-6. PubMed ID: 1671646
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacokinetic and pharmacodynamic studies on high doses of fluphenazine.
    Dencker SJ; Johansson R; Malm U
    Psychopharmacology (Berl); 1988; 94(2):237-41. PubMed ID: 3127851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of -141C Ins/Del Polymorphism in DRD2 Gene on Clinical Symptoms and Plasma Homovanillic Acid Levels in the Treatment of Schizophrenia With Aripiprazole.
    Miura I; Kanno-Nozaki K; Hino M; Horikoshi S; Ota T; Mashiko H; Niwa S; Yabe H
    J Clin Psychopharmacol; 2015 Jun; 35(3):333-4. PubMed ID: 25871573
    [No Abstract]   [Full Text] [Related]  

  • 36. Morning variations of plasma homovanillic acid in untreated schizophrenic patients.
    Zumárraga M; Andía I; Bárcena B; González-Torres MA; Dávila R
    J Psychiatr Res; 1993; 27(1):11-6. PubMed ID: 8515382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma homovanillic acid and treatment response in a large group of schizophrenic patients.
    Chang WH; Hwu HG; Chen TY; Lin SK; Lung FW; Chen H; Lin WL; Hu WH; Lin HN; Chien CP
    Schizophr Res; 1993 Oct; 10(3):259-65. PubMed ID: 8260444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Idazoxan, an alpha 2 antagonist, augments fluphenazine in schizophrenic patients: a pilot study.
    Litman RE; Hong WW; Weissman EM; Su TP; Potter WZ; Pickar D
    J Clin Psychopharmacol; 1993 Aug; 13(4):264-7. PubMed ID: 8104200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls.
    Davidson M; Davis KL
    Arch Gen Psychiatry; 1988 Jun; 45(6):561-3. PubMed ID: 3377642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in symptoms and plasma homovanillic acid with amantadine hydrochloride in chronic schizophrenia.
    Yamada K; Kanba S; Ohnishi K; Ashikari I; Yagi G; Asai M
    Biol Psychiatry; 1997 May; 41(10):1062-4. PubMed ID: 9129786
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.